India, March 10 -- Beckman Coulter Diagnostics, the clinical diagnostics unit of science and technology firm Danaher Corp. (DHR), announced Monday that the new DxC 500i Clinical Analyzer received 510(k) clearance from the U.S. Food and Drug Administration.
The DxC 500i Clinical Analyzer is an integrated clinical chemistry and immunoassay analyzer. The analyzer, with throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay tests per hour, delivers precise and reliable results critical for timely clinical decision-making.
It combines advanced technology with an intuitive user interface, ensuring that laboratories of all sizes can meet the growing demands of modern healthcare.
The DxC 500i analyzer incorporates the DxC ...